Financhill
Back

Carlisle Companies Vs. NovoCure Industry Stock Comparison

Sell
36

CSL
Carlisle Companies

Last Price:
$378.28
Seasonality Move:
6.71%
Sell
49

NVCR
NovoCure

Last Price:
$31.91
Seasonality Move:
-8.57%
Sell
36
Carlisle Companies (CSL) is a Sell

Is Carlisle Companies a Buy, Sell or Hold?

  • The current Carlisle Companies [CSL] share price is $376.45. The Score for CSL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CSL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.97. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CSL Stock Price Chart

What is Carlisle Companies's stock price today?

  • The Carlisle Companies share price today is $376.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CSL is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -17.68 Sell
Relative Strength Index (14 RSI): 21.3 Sell
Chaikin Money Flow: 36050 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (398.4 - 454.12) Sell
Bollinger Bands (100): (401.07 - 454.83) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.02 Buy
Relative Strength Index (14 RSI): 64.15 Buy
Chaikin Money Flow: 291530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.5 - 32.28) Buy
Bollinger Bands (100): (14.36 - 24.58) Buy

CSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 391.77 Sell
20-day SMA: 421.44 Sell
50-day SMA: 436.41 Sell
200-day SMA: 415.31 Sell
8-day EMA: 390.45 Sell
20-day EMA: 411.36 Sell
50-day EMA: 426.62 Sell
200-day EMA: 405.46 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.43 Sell
20-day SMA: 28.64 Buy
50-day SMA: 21.62 Buy
200-day SMA: 18.41 Buy
8-day EMA: 30.72 Buy
20-day EMA: 28.28 Buy
50-day EMA: 23.76 Buy
200-day EMA: 20.64 Buy

Carlisle Companies Earnings Growth & CSL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.22 per share, and an increase next year of $2.58 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

Carlisle Companies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):